Isavuconazole safe and effective to treat aspergillus infection in patients with cancer
the ONA take:
According to new research presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2014), isavuconazole is as effective as voriconazole for the treatment of aspergillus infection in patients with cancer. In the phase 3 study comparing isavuconazole, new antifungal agent, with voriconazole in patients with uncontrolled cancer, researchers found that the two agents were equally efficacious against the invasive fungal disease.
Furthermore, researchers observed fewer adverse effects associated with isavuconazole versus voriconazole. Compared with those that took voriconzaole, patients who took isavuconazole had less ocular, epidermal, and hepatobiliary toxicity.
Fungal infections caused by aspergillus and other fungi can be particularly harmful in immunocompromised patients undergoing treatment for cancer. These fungal infections often increase morbidity and mortality in these patients, especially those with hematological malignancies like leukemia and lymphoma.
Based on the results of the study, Astellas and Basilea Pharmaceutica International Ltd. have submitted a new drug application to the U.S. Food and Drug Administration (FDA) for isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis.
Isavuconazole as effective as voriconazole for treatment of aspergillus infection in patients with cancer.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|